Clinical Trials
8 trialsNCT04305444 2025-01-08
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Zhejiang DTRM Biopharma
Phase 2 Terminated
NCT04730349 2023-03-24
PIVOT IO 020
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT01039376 2019-07-30
PROLONG
Novartis
Phase 3 Terminated
NCT00748189 2019-06-25
COMPLEMENT 1
Novartis
Phase 3 Terminated
NCT02848911 2019-06-19
Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL
Affimed GmbH
Phase 1 Terminated
NCT02227108 2017-04-06
Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
MedImmune LLC
Phase 2 Terminated
NCT02273856 2016-06-21
NADIR
Astellas Pharma Inc
Terminated
NCT00083473 2005-08-30
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
Titan Pharmaceuticals
Phase 2 Terminated